Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-05-17 @ 4:39 PM
Study NCT ID:
NCT05228951
Status:
RECRUITING
Last Update Posted:
2022-09-13
First Post:
2022-01-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC
Sponsor:
Organization: